GSK to buy stake in South Africa's Aspen
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline is planning to buy a stake in Africa's largest pharmaceutical firm Aspen Pharmacare. The move will bring it closer to the generic manufacturer, whose revenues grew by 91% to R4.264 billion ($447.8 million) for the six months ended December 31st, 2008.